Correlation Between Revolution Medicines and 4D Molecular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and 4D Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and 4D Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and 4D Molecular Therapeutics, you can compare the effects of market volatilities on Revolution Medicines and 4D Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of 4D Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and 4D Molecular.

Diversification Opportunities for Revolution Medicines and 4D Molecular

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Revolution and FDMT is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and 4D Molecular Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 4D Molecular Therapeutics and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with 4D Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 4D Molecular Therapeutics has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and 4D Molecular go up and down completely randomly.

Pair Corralation between Revolution Medicines and 4D Molecular

Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.62 times more return on investment than 4D Molecular. However, Revolution Medicines is 1.61 times less risky than 4D Molecular. It trades about 0.06 of its potential returns per unit of risk. 4D Molecular Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  2,432  in Revolution Medicines on August 24, 2024 and sell it today you would earn a total of  3,243  from holding Revolution Medicines or generate 133.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Revolution Medicines  vs.  4D Molecular Therapeutics

 Performance 
       Timeline  
Revolution Medicines 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, Revolution Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.
4D Molecular Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 4D Molecular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Revolution Medicines and 4D Molecular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Revolution Medicines and 4D Molecular

The main advantage of trading using opposite Revolution Medicines and 4D Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, 4D Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4D Molecular will offset losses from the drop in 4D Molecular's long position.
The idea behind Revolution Medicines and 4D Molecular Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios